2989 Risk Indicators For Jointly Occurring Oral Candidiasis And Hairy Leukoplakia
A. CHATTOPADHYAY1, L.L. PATTON2, and D.J. CAPLAN2, 1Temple University, Philadelphia, PA, USA, 2University of North Carolina, Chapel Hill, USA

Occurrence of oral candidiasis (OC) and oral hairy leukoplakia (OHL) singly or together in HIV-1 infected persons may reflect an impaired oral defense system. Literature describing joint occurrence of these diseases is sparse. Objective: To develop an explanatory multivariable model for joint occurrence of OC and OHL. Methods: This cross-sectional study evaluated 631 adult dentate HIV-1 seropositive persons (race: White/ Black only) examined for OC and OHL from 1995 - 2000 at the University of North Carolina Hospitals in Chapel Hill, NC. Data collected from medical record review, interview questionnaires and clinical examinations were analyzed using chi-sq tests, t-tests, and ANOVA. Multivariable proportional odds models were developed, employing likelihood ratio test, using those without OC or OHL as the outcome reference group. Independent variables included: age, race, sex, sexual orientation, smoking, recreational drug use, CD4 cell count, antiretroviral medication use, and antifungal medication use. Results: Thirteen percent of participants had OC only; 12.8% had OHL only; 4.6% had both OC and OHL; whereas 69.7% had neither. Higher odds for joint occurrence of OC and OHL were associated with CD4+ counts < 200 cells/ml [adj. OR (95%CI) = 13.4 (6.6, 27.2)] and CD4+ counts 200-499 cells/mL [OR= 3.9 (1.9, 8.1)]; current smokers [OR= 2.3 (1.4, 3.8)]; and Whites [OR= 1.7 (1.1, 2.5)]. Race was not a significant risk indicator for each condition separately. Combination antiretroviral therapy was protective [OR= 0.5 (0.3, 0.9)]. Conclusions: These data established independent risk indicators for joint occurrences of OC and OHL in an HIV-1 infected population. Lower CD4 cell count, smoking, and White race were important risk indicators for joint occurrence of OC and OHL. (Supported by NIH: DE11369, 5T32DE07191, and P30-HD27360)

Seq #324 - Senior Category
10:15 AM-11:30 AM, Saturday, 13 March 2004 Hawaii Convention Center Exhibit Hall 1-2

Back to the AADR/Pfizer Hatton Awards Program
Back to the IADR/AADR/CADR 82nd General Session (March 10-13, 2004)

Top Level Search